Etova 400mg Tablet ER 10s

Etova-ER 400 Tablet is effective if used in the dose and duration advised by your doctor. Do not stop taking it even if you see improvement in your condition. If you stop using Etova-ER 400 Tablet too early, the symptoms may return or worsen.

No, Etova-ER 400 Tablet does not get you high. It does not have an abuse potential (drug-seeking behavior) and does not cause physical or psychological dependence. However, if you do not feel well, consult your doctor.

Long-term use and high doses of Etova-ER 400 Tablet may cause renal problems, such as protein or blood in urine and pain during urination. Patients who had or have heart failure, impaired kidney function and hypertension are at risk of kidney problems. The risk of developing kidney problems is also high in patients who are on medicines which cause excess urination (diuretics), or medicines which have significant impact on kidney function. Along with that, Etova-ER 400 Tablet can affect kidneys of patients who are above 65 years of age or who remain dehydrated. Therefore, kidney function monitoring is recommended for such patients.

These belong to a family of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). Etoricoxib helps to reduce the pain and swelling (inflammation) in the joints and muscles of people 16 years of age and older with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout.

Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain, and helps to relieve symptoms of arthritis (osteoarthritis and rheumatoid arthritis), such as inflammation, swelling, stiffness, and joint pain.

The only adverse drug reaction reported was stomach pain in one of the 81 patients. It can be concluded that etodolac is an effective and well-tolerated non-steroidal anti-inflammatory agent in the treatment of lumbar disc herniation.

A: Etova Er 400mg Tablet is a painkiller medicine used to treat various types of pain such as dental pain, muscular pain and postoperative pain, and it is also used to relieve pain associated with gout.

A: Etova Er 600mg Tablet is a painkiller medicine used to treat various types of pain such as dental pain, muscular pain and postoperative pain, and it is also used to relieve pain associated with gout.

Use of Etova-ER 400 Tablet should be avoided in patients who are allergic to Etova-ER 400 Tablet or any of its components. However, if you are not aware of any allergy or if you are using Etova-ER 400 Tablet for the first time, consult your doctor.

Introduction. Etodolac is a nonsteroidal antiinflammatory drug (NSAID) that is available by prescription only and is used long term for therapy of chronic arthritis and short term for acute pain. Etodolac has been linked to rare instances of clinically apparent drug induced liver disease.

Etodolac is used to relieve pain from various conditions. It also reduces pain, swelling, and joint stiffness from arthritis. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your bodys production of certain natural substances that cause inflammation.

Etova-ER 400 Tablet can cause drowsiness and also dizziness, fatigue (tiredness) and visual disturbances. However, it is not very common and may not affect everyone. If you experience these symptoms avoid driving or operating heavy machinery.

Etodolac oral tablet does not cause drowsiness. However, it can cause other side effects.

Both dosages of etodolac were found to be similar in effectiveness to the ibuprofen dosage. In terms of side effects, those taking etodolac experienced less indigestion, rash, and stomach bleeding than those taking ibuprofen. However, this may be related to the amounts of drug patients were given.

No, Etova-ER 400 Tablet is not a narcotic. It belongs to non-steroidal anti-inflammatory drugs (NSAIDs) group of medicines.

The results suggest that etodolac does not affect renal function in normal individuals, nor does it exacerbate underlying renal insufficiency when administered to patients with mild to moderate renal impairment. The pharmacokinetics of etodolac are unchanged in patients on hemodialysis and in elderly patients.